Management of Chronic Airflow Obstruction

Slides:



Advertisements
Similar presentations
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Advertisements

Use of Medications in Asthma Cyril Grum, M.D. Department of Internal Medicine *Based on the University of Michigan Guidelines for Clinic Care and the National.
STATUS ASTHMATICUS Sigrid Hahn, MD Andy Jagoda, MD, FACEP Department of Emergency Medicine Mount Sinai School of Medicine New York, New York.
Michael W. Nash, MD Family Medicine Clinton County Rural Health Clinic Understanding COPD.
AsthmaAsthma is a condition characterized by paroxysmal narrowing of the bronchial airways due to inflammation of the bronchi and contraction of the bronchial.
Respiratory Diseases Pathophysiology and Medical Treatments.
COPD All you wanted to know about COPD but were afraid to ask…
CHRONIC OBSTRUCTIVE PULMONARY DISEASE Treatment Opportunities in a Heartsink Disease Jim Reid.
Management of Asthma and COPD
Drugs For Treating Asthma
COPD Joshua Jewell. Epidemiology 8% of all individuals 10% age >40 6 th leading cause of death worldwide th in U.S. - >120,000 Expected 3 rd 2020.
Central Ohio Pulmonary Disease, Inc. Michael L. Corriveau, MD, FACP, FCCP.
Chronic Obstructive Pulmonary Disease and Asthma: All That Wheezes? Clifford Courville, MD Pulmonary, Allergy, and Critical Care.
COPD Management of Stable COPD Shyam Rao May 2014.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
Week 4: Asthma and COPD Dr Felix Woodhead Consultant Physician.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 76 Drugs for Asthma.
Asthma Management Pathophysiology and Management University of Utah Center for Emergency Programs and The Utah Asthma Program.
Management of Chronic Airflow Obstruction J.R. Sheller, M.D. Allergy, Pulmonary & Critical Care Medicine.
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Case No. 12 SH, 25 years old with a history of asthma since childhood presented to the OPD clinic with complaints of worsening dyspnea and wheezing. He.
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
 Definition  Asthma is a chronic inflammatory disorder of the lung airways, characterised by reversible airway obstruction, airway hyper-responsiveness,
Definition COPD def- A disease state characterized by air flow limitation that is not fully reversible It is expected to be the 3 rd leading cause of.
NYU Medical Grand Rounds Clinical Vignette Verity Schaye, MD PGY-3 September 15, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
Chronic Obstructive Pulmonary Disease Austin Paul K.
Percent Change in Age-Adjusted Death Rates, U.S., Proportion of 1965 Rate –59% –64% –35% +163% –7% Coronary.
Management of Patients With Chronic Pulmonary Disease
Bronchodilators and Other Respiratory Agents
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
Prof.Dr. Muhi K. Aljanabi MRCPCH; DCH; FICMS Consultant Pediatric Pulmonologist.
Webinar: Managing Asthma in the Job Corps Student John Kulig, MD, MPH Lead Medical Specialist September 7 th and 15 th, 2011.
Management Of Exacerbations Of Chronic Obstructive Pulmonary Disease D.Anan Esmail Seminar Training Primary Care Asthma + COPD
СOPD Chronic obstructive pulmonary disease (COPD), a common preventable and treatable disease, is characterized by persistent airflow limitation that.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
ASTHMA Definition: Asthma is a chronic lung disease due to inflammation of the airways resulted into airway obstruction. The obstruction is reversible.
Management Of Exacerbations Of Chronic Obstructive Pulmonary Disease D.Anan Esmail Seminar Training Primary Care Asthma + COPD
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
Dr Mazen Qusaibaty MD, DIS / Head Pulmonary and Internist Department Ibnalnafisse Hospital Ministry of Syrian health – Dr Mazen.
Asthma ( Part 1 ) Dr.kassim.M.sultan F.R.C.P. Objectives: 1-Define asthma 2-Identify its aggravating factors 3-Describe its clinical features 4-Illustrate.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.1 Respiratory Medications.
Respiratory Health Asthma and COPD. Definition of asthma 2 Working definition by AAH 2014: Chronic lung disease Can be controlled not cured Large variation.
Asthma and COPD Some highlights. How the lungs work 2.
Current management of COPD and when to refer?
COPD 2003.
Chronic Obstructive Pulmonary Disease(COPD)
Pharmacology of Anti- Asthmatic Medications
Eileen G. Holland, Pharm.D., BCPS Associate Professor
Asthma guidelines and treatment
Managing acute exacerbations of COPD in primary care.
Management of Severe Asthma and COPD
Therapeutics 2 Tutoring: Asthma
COPD Tutoring – Part 1 By Alaina Darby.
COPD PATHWAY AND PRESCRIBING POLICY IN LAMA options (stop SAMA):
COPD Tutoring – Part 2 By Alaina Darby.
Bronchial Asthma Dr.Radhakrishna. S. A. Bronchial Asthma Dr.Radhakrishna. S. A.
COPD By Alaina Darby.
Asthma Presented by Qassim j. odaa Master M.S.N..
Asthma By Alaina Darby.
Asthma/ Wheeze and children
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Chronic obstructive pulmonary disease
COPD Exacerbations UCI Internal Medicine Mini-Lecture
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Chronic Obstructive Pulmonary Disease
William P. Saliski Jr. DO Montgomery Pulmonary Consultants
Chronic Obstructive Pulmonary Disease
Respiratory Unit Questions
Presentation transcript:

Management of Chronic Airflow Obstruction J.R. Sheller, M.D. Allergy, Pulmonary & Critical Care Medicine Pierre: 42% smoked 30yrs ago, now 22%. Lung Cancer 87% are smokers. It is declining. Feb 6, 2007

COPD DX: Chronic obstructive bronchitis and emphysema 72 year old smoker for 60yrs Cough, sputum production, dyspnea FEV1 33% predicted; DLCO 25% predicted No bronchodilator response to albuterol Rhonchi, wheezes, pedal edema DX: Chronic obstructive bronchitis and emphysema http://www.goldcopd.com/

Check alpha one antitrypsin level Smoking history If absent consider other dx (immunodeficiency, ciliary dysfunction, cystic fibrosis) Check alpha one antitrypsin level In patients with early disease (<45yoa) In patients with family history of COPD

Bronchodilators Beta2 adrenergic agonists By metered dose inhaler By dry powder inhaler By nebulizer Short acting – albuterol, terbutaline – rescue medicine Long acting – salmeterol, formoterol Not used for “rescue”

Anticholinergics Ipratropium Tiatropium Work best in COPD Viral exacerbations of asthma in children

Smoking Cessation Counseling Has patient thought about stopping? Rehearse reasons to quit Offer to help Group therapy – quitting sessions Cancer Society, Heart Assoc., Lung Assoc. Medications Wellbutrin Nicotine Clonidine Vaccination vs nicotine Cannabinoid receptor antagonist Schroeder SA. What to do with a patient who smokes. JAMA. 2005 Jul 27;294(4):482-7.

Other Treatments Inhaled corticosteroids for severe COPD with frequent exacerbations Antibiotics For increased and purulent sputum (amoxicillin, doxycycline, macrolides, trimethoprim/sulfa) For hospitalized exacerbations – consider broader spectrum (pseudomonas)

Calls with low grade fever, dyspnea, ankle edema, increased sputum Admitted to hospital with SaO2 75% Oxygen by nasal prongs BiPAP (non invasive ventilation) Systemic steroids – iv methylprednisolone, convert to oral (60mg prednisone) Nebulized ipratropium/albuterol Diuretic – furosemide Antibiotics – (levofloxacin, cefipime, etc) Pneumovax, influenza vaccine

COPD Rx Smoking cessation Inhaled ipratropium, beta agonist using MDI Long acting – tiotropium Flu vaccine, pneumovax Antimicrobials for increased sputum (amoxicillin, doxycycline, macrolides, trimethoprim/sulfa) Inhaled corticosteroids for severe dz Pulmonary rehabilitation Avoid oral steroids

Home Oxygen Home oxygen tethers patients, causing deconditioning SaO2 <89% (or pulmonary hypertension, Hct >55, CHF) Should be used 24hrs day After 6 weeks, recheck sats (50% of patients no longer need it) Home oxygen tethers patients, causing deconditioning Pulmonary rehab, activity are important

35 year old female with episodic cough, wheezing, dyspnea after jogging Childhood history of asthma Atopic (hay fever) Normal exam FEV1 normal; FEV1/FVC reduced

Albuterol MDI prior to exercise Medication works, but she uses it each day Add inhaled steroids Now awakening at night with cough Add long acting beta agonist (salmeterol, formoterol; or combination, eg Advair, Symbicort) Rehearse inhaler use, action plan Allergy/Pulmonary consultation http://www.nhlbi.nih.gov/about/naepp/

Convenient, cheap Beclomethasone – 2 puffs QID Triamcinalone – 2 inhalations TID Fluticasone – 2 inhalations BID (3 strengths) Flunisolide – 2 inhalations BID Budesonide – 2 inhalations BID Convenient, cheap

Still having problems with dyspnea, uses albuterol several times a day GERD, Sinus disease Add leukotriene modifier Montelukast, zafirlukast – receptor blockers Zileuton – inhibitor of 5-lipoxygenase Increase inhaled steroids Consider theophylline Anti IgE (omalizumab)

Leukotriene Modifiers Zileuton – 5 Lipoxygenase inhibitor Receptor antagonist Zafirlukast 20mg BID Montelukast 10mg QD

Has symptoms of URI, using albuterol every 2hrs, not getting relief ED Rx Oxygen Continuous albuterol Intravenous methylprednisolone 125mg Ipratropium Mg may help those with most severe obstruction Measure PEFR, FEV1, pulsus paradoxus Admit in 2hrs if no improvement

Risk of death in Asthma Frequent hospitalizations Intubated for asthma Poor perception of airflow obstruction Frequent albuterol rescue medication use Psychosocial problems